In tumor xenograft formation assay, we found that miR-424-5p overexpression or silencing BCL9L alone slightly suppressed tumor formation of HuCCT1-Gem cells, but dramatically increased gemcitabine sensitivity and reduced tumor growth when treated with gemcitabine (Figure S7C–E). This evidence concerns the gene GEM and neoplasm.